Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 111
interventional 85
Observational 23
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 41
Device 9
Drug|placebo 9
Procedure 9
Other 4
Combination Product 2
Dietary Supplement 2
Biological|Drug 1
Biological|placebo 1
Combination Product|Procedure 1
Device|Drug 1
Device|Drug|Procedure 1
Dietary Supplement|placebo 1
Drug|Other 1
Drug|Other|placebo 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 18
Taiwan 12
Korea, Republic of 9
NA 8
United States 8
Denmark 3
Hong Kong 3
Egypt 2
Germany 2
Italy 2
Singapore 2
Austria|Denmark|Finland|France|Germany|Greece|Hong Kong|Netherlands|Norway|Romania|Russian Federation|South Africa|Spain|Sweden|Turkey|United Kingdom 1
Belgium|France|Greece|Hungary|Poland|Spain 1
Brazil 1
Canada 1
Canada|Hong Kong|Netherlands|United Kingdom 1
China|Korea, Republic of|Philippines|Taiwan 1
Czech Republic 1
Greece 1
India 1
Iran, Islamic Republic of 1
Netherlands 1
Russian Federation 1
Thailand 1
Turkey 1
United States|Argentina|Australia|Bulgaria|Canada|Czech Republic|Finland|Germany|Indonesia|Korea, Republic of|Mexico|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Thailand 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 69
2 4
4 1
6 1
7 1
10 1
12 2
18 1
22 1
23 1
79 1
81 1
192 1

Phase

Phase Study_Count
Phase 4 30
N/A 29
Phase 3 15
Phase 2 5
Phase 1 4
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 8
2 51
3 9
4 4
5 1
6 1
7 1
NA 10

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 7.0000 24.00 12 30 100.0000 40.0000
1st Qu. 76.0000 90.75 88 58 210.5000 91.0000
Median 116.0000 125.50 165 86 263.0000 161.0000
Mean 234.3448 106.25 163 86 550.7333 349.0345
3rd Qu. 228.0000 141.00 180 114 583.5000 424.0000
Max. 2024.0000 150.00 370 142 2426.0000 3157.0000

Trial Group Type

group_type Group_Count
Experimental 72
Active Comparator 71
Placebo Comparator 17
NA 10
No Intervention 7
Other 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 71
Single Group Assignment 10
NA 3
Crossover Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 51
Prevention 21
NA 6
Diagnostic 2
Screening 2
Supportive Care 2
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 7
China 4
Spain 2
Hong Kong 1
Italy 1
Japan 1
Korea, Republic of 1
Latvia 1
Latvia|Lithuania 1
NA 1
Norway 1
Switzerland 1
Syrian Arab Republic 1

Sites per Study

Site_count Study_Count
1 17
2 2
3 1
12 1
31 1
47 1

Enrollment Metrics

Measure Observational
Min 30.000
1st Qu 206.000
Median 353.000
Mean 2454.609
3rd Qu 974.000
Max 39000.000

Observation Model

observational_model Study_Count
Cohort 14
Case Control 5
NA 2
Case-Control 1
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 12
Retrospective 8
Cross-Sectional 1
Other 1
NA 1

Registries

Studies by Country

Country Study_Count
Canada|Iran, Islamic Republic of|Japan 1
Korea, Republic of 1
Norway 1

Sites per Study

Site_count Study_Count
1 1
2 1
3 1

Enrollment Metrics

Measure Registries
Min 543.0000
1st Qu 717.5000
Median 892.0000
Mean 978.3333
3rd Qu 1196.0000
Max 1500.0000

Registry Model

observational_model Study_Count
Cohort 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
1 Day 1
1 Year 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04039646 ERAS in Patients With Perforated Peptic Ulcer Disease Who Underwent Laparoscopic Repair https://ClinicalTrials.gov/show/NCT04039646 Recruiting Beijing Chao Yang Hospital 2021-12-31
NCT03362281 Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients https://ClinicalTrials.gov/show/NCT03362281 Completed Livzon Pharmaceutical Group Inc. 2015-04-30
NCT03362268 IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients https://ClinicalTrials.gov/show/NCT03362268 Completed Livzon Pharmaceutical Group Inc. 2014-06-30
NCT03320538 Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases https://ClinicalTrials.gov/show/NCT03320538 Recruiting Jiangxi University of Traditional Chinese Medicine 2021-12-31
NCT03160911 The Use of Over-the-scope-clip for Prevention of Rebleeding in High Risk Peptic Ulcers https://ClinicalTrials.gov/show/NCT03160911 Recruiting Chinese University of Hong Kong 2021-04-30
NCT03123835 Outcome Analysis of POEM and Endoluminal Therapies https://ClinicalTrials.gov/show/NCT03123835 Enrolling by invitation University of California, Davis 2021-12-31
NCT03050307 Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection https://ClinicalTrials.gov/show/NCT03050307 Completed Takeda 2020-02-19
NCT02978391 UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD https://ClinicalTrials.gov/show/NCT02978391 Completed Next Biomedical Co., Ltd. 2016-11-30
NCT02648659 The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients https://ClinicalTrials.gov/show/NCT02648659 Completed Kyungpook National University Hospital 2017-01-06
NCT02633930 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy https://ClinicalTrials.gov/show/NCT02633930 Completed Xijing Hospital of Digestive Diseases 2016-06-30
NCT02581696 The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT02581696 Completed Boryung Pharmaceutical Co., Ltd 2015-11-30
NCT02551744 Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers https://ClinicalTrials.gov/show/NCT02551744 Completed Kaohsiung Veterans General Hospital. 2018-07-31
NCT02536989 Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot https://ClinicalTrials.gov/show/NCT02536989 Completed Far Eastern Memorial Hospital 2012-06-30
NCT02456012 Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients https://ClinicalTrials.gov/show/NCT02456012 Recruiting National Cheng-Kung University Hospital 2020-02-29
NCT02418312 Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer https://ClinicalTrials.gov/show/NCT02418312 Completed Kaohsiung Veterans General Hospital. 2017-10-31
NCT02342470 Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users https://ClinicalTrials.gov/show/NCT02342470 Completed PharmaKing 2017-12-08
NCT02296021 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy https://ClinicalTrials.gov/show/NCT02296021 Completed Xijing Hospital of Digestive Diseases 2015-09-30
NCT02241044 Argon Plasma Coagulation for Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT02241044 Completed Kaohsiung Veterans General Hospital. 2012-01-31
NCT02175901 Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication https://ClinicalTrials.gov/show/NCT02175901 Completed Shanghai Jiao Tong University School of Medicine 2015-01-31
NCT02175186 Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT02175186 Recruiting Asan Medical Center 2019-12-31
NCT02166008 Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT https://ClinicalTrials.gov/show/NCT02166008 Completed King Chulalongkorn Memorial Hospital 2017-06-30
NCT02088385 Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study https://ClinicalTrials.gov/show/NCT02088385 Completed Changi General Hospital 2015-03-31
NCT02084420 Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment https://ClinicalTrials.gov/show/NCT02084420 Completed Il-Yang Pharm. Co., Ltd. 2014-01-31
NCT01306864 Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding https://ClinicalTrials.gov/show/NCT01306864 Completed Cook Group Incorporated 2017-04-30
NCT01282853 Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01282853 Completed Far Eastern Memorial Hospital 2011-06-30
NCT02020603 Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT02020603 Completed Kyunghee University Medical Center 2014-06-30
NCT01838109 Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT01838109 Completed Seoul National University Hospital 2014-04-30
NCT01828645 Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein https://ClinicalTrials.gov/show/NCT01828645 Completed Federal University of Mato Grosso 2013-03-31
NCT01822600 The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia https://ClinicalTrials.gov/show/NCT01822600 Completed National Cheng-Kung University Hospital 2011-08-31
NCT01757275 High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer https://ClinicalTrials.gov/show/NCT01757275 Completed AstraZeneca 2014-12-31
NCT01675856 Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB) https://ClinicalTrials.gov/show/NCT01675856 Completed Chinese University of Hong Kong 2018-11-11
NCT01668927 Empirical Rescue Therapies of Helicobacter Pylori Infection https://ClinicalTrials.gov/show/NCT01668927 Completed Shanghai Jiao Tong University School of Medicine 2012-09-30
NCT01667718 Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment https://ClinicalTrials.gov/show/NCT01667718 Completed Shanghai Jiao Tong University School of Medicine 2012-10-31
NCT01667692 Aizthromycin or Clarithromycin in H-pylori Eradication Regimen https://ClinicalTrials.gov/show/NCT01667692 Completed Shahid Sadoughi University of Medical Sciences and Health Services 2011-11-30
NCT01667575 Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori https://ClinicalTrials.gov/show/NCT01667575 Completed Shanghai Jiao Tong University School of Medicine 2013-05-31
NCT01620671 Fast-track Surgery for Perforated Peptic Ulcers https://ClinicalTrials.gov/show/NCT01620671 Completed Bakirkoy Dr. Sadi Konuk Research and Training Hospital 2013-01-31
NCT01591083 The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT01591083 Completed National Cheng-Kung University Hospital 2014-07-31
NCT01560702 Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers https://ClinicalTrials.gov/show/NCT01560702 Completed Zagazig University 2013-09-30
NCT01524081 Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures https://ClinicalTrials.gov/show/NCT01524081 Completed The Faculty Hospital Na Bulovce 2011-07-31
NCT01453036 Clarithromycin Resistant Tailored Therapy https://ClinicalTrials.gov/show/NCT01453036 Completed The Catholic University of Korea 2012-06-30
NCT01447498 Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment https://ClinicalTrials.gov/show/NCT01447498 Completed Odense University Hospital 2014-05-31
NCT01353144 A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers https://ClinicalTrials.gov/show/NCT01353144 Completed Kaohsiung Veterans General Hospital. 2008-05-31
NCT04432233 Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease https://ClinicalTrials.gov/show/NCT04432233 Recruiting Shanghai Jiao Tong University School of Medicine 2021-04-15
NCT04366583 Argon Plasma Coagulation vs Hemoclipping for Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT04366583 Completed Kaohsiung Veterans General Hospital. 2016-02-28
NCT04239118 New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers https://ClinicalTrials.gov/show/NCT04239118 Completed Voronezh N.N. Burdenko State Medical Academy 2019-06-16
NCT04194060 ERAS vs Conventional Approach in Peptic Perforation-RCT https://ClinicalTrials.gov/show/NCT04194060 Recruiting All India Institute of Medical Sciences, Bhubaneswar 2021-06-30
NCT04025983 Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection https://ClinicalTrials.gov/show/NCT04025983 Recruiting Institute of Gastroenterology and Hepatology, Vietnam 2020-05-31
NCT03814421 Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT03814421 Recruiting Samsung Changwon Hospital 2018-12-31
NCT03785015 When Should Low-dose Aspirin be Resumed After Peptic Ulcer Bleeding? https://ClinicalTrials.gov/show/NCT03785015 Recruiting Chinese University of Hong Kong 2024-02-28
NCT03733171 Platelet Rich Plasma in Bleeding Peptic Ulcer https://ClinicalTrials.gov/show/NCT03733171 Recruiting Zagazig University 2019-06-01
NCT03675672 Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer https://ClinicalTrials.gov/show/NCT03675672 Recruiting Chinese University of Hong Kong 2021-05-30
NCT03551262 Over-the-scope Clip Versus Through-the-scope Clip for Endoscopic Hemostasis of High Risk Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT03551262 Recruiting Azienda USL Modena 2020-10-26
NCT03469167 Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding https://ClinicalTrials.gov/show/NCT03469167 Completed CGBio Inc. 2015-11-10
NCT01180179 PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers https://ClinicalTrials.gov/show/NCT01180179 Completed Chinese University of Hong Kong 2019-05-31
NCT01142245 Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy https://ClinicalTrials.gov/show/NCT01142245 Completed Chinese University of Hong Kong 2013-12-31
NCT01142180 Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis https://ClinicalTrials.gov/show/NCT01142180 Completed Chinese University of Hong Kong 2014-07-31
NCT01138969 Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer https://ClinicalTrials.gov/show/NCT01138969 Completed Kaohsiung Veterans General Hospital. 2012-12-31
NCT01125852 Supplementary Angiographic Embolization for Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01125852 Completed Odense University Hospital 2012-05-31
NCT01080326 Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus https://ClinicalTrials.gov/show/NCT01080326 Completed Mayo Clinic 2012-12-31
NCT00998075 Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately https://ClinicalTrials.gov/show/NCT00998075 Completed AstraZeneca 2009-12-31
NCT00843063 Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion https://ClinicalTrials.gov/show/NCT00843063 Completed Ruttonjee Hospital 2008-12-31
NCT00840008 The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT00840008 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2009-12-31
NCT00778193 Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers https://ClinicalTrials.gov/show/NCT00778193 Completed Research Associates of New York, LLP 2008-03-31
NCT00731601 Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT00731601 Completed Lotung Poh-Ai Hospital 2009-03-31
NCT00624169 Peptic Ulcer Perforation Study https://ClinicalTrials.gov/show/NCT00624169 Completed Copenhagen University Hospital at Herlev 2009-12-31
NCT00613665 Safety and Immunogenicity of Chiron’s Investigational H. Pylori Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT00613665 Completed Novartis 2001-12-31
NCT00557349 Ulcer Prevention Study in Post Gastric Bypass Patients https://ClinicalTrials.gov/show/NCT00557349 Completed University of Missouri-Columbia 2007-11-30
NCT00573924 Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers https://ClinicalTrials.gov/show/NCT00573924 Completed University of Southern California NA
NCT00534443 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment https://ClinicalTrials.gov/show/NCT00534443 Completed University of Athens 2009-09-30
NCT00519519 Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT00519519 Completed Singapore General Hospital 2007-10-31
NCT00450658 Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers https://ClinicalTrials.gov/show/NCT00450658 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2008-09-30
NCT00441727 Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) https://ClinicalTrials.gov/show/NCT00441727 Completed AstraZeneca 2008-08-31
NCT00374101 High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT00374101 Completed Casa Sollievo della Sofferenza IRCCS NA
NCT00325715 AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00325715 Completed Allergan 2006-08-31
NCT00279123 Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers https://ClinicalTrials.gov/show/NCT00279123 Completed Kwong Wah Hospital NA
NCT00261300 Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) https://ClinicalTrials.gov/show/NCT00261300 Completed Takeda 2007-09-30
NCT00175032 A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin https://ClinicalTrials.gov/show/NCT00175032 Completed Takeda 2004-07-31
NCT00164931 A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer https://ClinicalTrials.gov/show/NCT00164931 Completed Chinese University of Hong Kong NA
NCT00164866 Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy https://ClinicalTrials.gov/show/NCT00164866 Completed Chinese University of Hong Kong NA
NCT00152399 Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT00152399 Completed UCB Pharma 2005-10-31
NCT00040495 Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage https://ClinicalTrials.gov/show/NCT00040495 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2003-01-31
NCT00037570 Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage https://ClinicalTrials.gov/show/NCT00037570 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2002-02-28
NCT00251979 A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer https://ClinicalTrials.gov/show/NCT00251979 Completed AstraZeneca 2007-12-31
NCT00137033 Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population https://ClinicalTrials.gov/show/NCT00137033 Completed Pfizer NA
NCT00745667 The LAMA Trial: Laparoscopic Correction of Perforated Peptic Ulcer Versus Open Correction https://ClinicalTrials.gov/show/NCT00745667 Completed Erasme University Hospital 2006-12-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03228095 Volatiles in Breath and Headspace Analysis - Diagnostic Markers https://ClinicalTrials.gov/show/NCT03228095 Enrolling by invitation University of Latvia 2019-12-20
NCT03163680 Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers https://ClinicalTrials.gov/show/NCT03163680 Completed Damascus Hospital 2018-05-01
NCT02332213 Volatile Markers in Digestive Cancer https://ClinicalTrials.gov/show/NCT02332213 Completed University of Latvia 2017-06-30
NCT02245802 Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT02245802 Completed Chinese University of Hong Kong 2012-04-30
NCT02165488 Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae https://ClinicalTrials.gov/show/NCT02165488 Completed The University of Hong Kong 2019-05-31
NCT01944878 The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient https://ClinicalTrials.gov/show/NCT01944878 Completed Chuncheon Sacred Heart Hospital 2013-08-31
NCT01888588 Risk of Uncomplicated Peptic Ulcer in the General Population https://ClinicalTrials.gov/show/NCT01888588 Completed AstraZeneca 2013-05-31
NCT01814943 The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users https://ClinicalTrials.gov/show/NCT01814943 Completed AstraZeneca 2013-05-31
NCT01591486 Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01591486 Completed Chinese University of Hong Kong 2013-02-28
NCT01476995 Prognostic Indicators as Provided by the EPIC ClearView https://ClinicalTrials.gov/show/NCT01476995 Completed Epic Research & Diagnostics, Inc. 2011-06-30
NCT01376414 H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department https://ClinicalTrials.gov/show/NCT01376414 Completed George Washington University 2014-08-31
NCT04447170 Laparoscopic Versus Open Repair of Peptic Ulcer Perforation https://ClinicalTrials.gov/show/NCT04447170 Enrolling by invitation University of Roma La Sapienza 2020-12-31
NCT04211194 Registry for Upper Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT04211194 Recruiting AdventHealth 2020-12-31
NCT03562026 S-CEI of Nexium in Paediatric Patients https://ClinicalTrials.gov/show/NCT03562026 Active, not recruiting AstraZeneca 2020-12-31
NCT01241266 China Survey of Peptic Ulcer Bleeding https://ClinicalTrials.gov/show/NCT01241266 Completed AstraZeneca 2011-07-31
NCT01041196 Perforated Marginal Ulcer After Gastric Bypass https://ClinicalTrials.gov/show/NCT01041196 Completed University of California, San Francisco 2009-01-31
NCT01041079 Chronic Marginal Ulcers After Gastric Bypass https://ClinicalTrials.gov/show/NCT01041079 Completed University of California, San Francisco 2009-12-31
NCT01040416 Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass https://ClinicalTrials.gov/show/NCT01040416 Completed University of California, San Francisco 2009-12-31
NCT00977678 Drop in Gastroscopy - Experience After 9 Months https://ClinicalTrials.gov/show/NCT00977678 Completed Norwegian Department of Health and Social Affairs 2009-12-31
NCT00920400 Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract https://ClinicalTrials.gov/show/NCT00920400 Completed University Hospital, Basel, Switzerland 2009-09-30
NCT02716025 Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection https://ClinicalTrials.gov/show/NCT02716025 Completed Ain Shams University 2015-08-31
NCT00212225 Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) https://ClinicalTrials.gov/show/NCT00212225 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00153712 Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers https://ClinicalTrials.gov/show/NCT00153712 Completed Chinese University of Hong Kong 2009-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03367897 Bleeding Ulcer and Erosions Study “BLUE Study” https://ClinicalTrials.gov/show/NCT03367897 Completed Ostfold Hospital Trust 2017-12-31
NCT02152904 Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study https://ClinicalTrials.gov/show/NCT02152904 Completed Incheon St.Mary’s Hospital 2015-12-31
NCT03868267 Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting https://ClinicalTrials.gov/show/NCT03868267 Recruiting Hamilton Health Sciences Corporation 2021-02-28